Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of Potential Biomarkers to Predict Tumor Response to Radiotherapy in Patients With Solid Tumors

NCT03744819 is registered in ClinicalTrials.gov with Chuangzhen Chen as lead sponsor.

NCT NCT03744819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03744819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of Potential Biomarkers to Predict Tumor Response to Radiotherapy in Patients With Solid Tumors
Lead sponsor
Chuangzhen Chen
Phase
Observational
Overall status
Recruiting
Start date
October 29, 2018
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors